STOCK TITAN
  1. Home
  2. Sec-filings
  3. SGHT
  4. [Form 4] Sight Sciences, Inc. Insider Trading Activity

[Form 4] Sight Sciences, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock SGHT logo
Sight Sciences, Inc.

NASDAQ:SGHT

SGHT Rankings

#4139 Ranked by Market Cap
N/A Ranked by Dividends

SGHT Latest News

Sep 2, 2025
Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO
Aug 26, 2025
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
Aug 7, 2025
Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
Jul 30, 2025
Sight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare® System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye Disease
Jul 29, 2025
Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye Disease

SGHT Latest SEC Filings

Aug 27, 2025
[8-K] Sight Sciences, Inc. Reports Material Event
Aug 7, 2025
[8-K] Sight Sciences, Inc. Reports Material Event
Jul 7, 2025
[Form 4] Sight Sciences, Inc. Insider Trading Activity
Jul 7, 2025
[Form 4] Sight Sciences, Inc. Insider Trading Activity
Jul 7, 2025
[Form 4] Sight Sciences, Inc. Insider Trading Activity

SGHT Stock Data

212.61M
41.41M
20.61%
50.32%
2.09%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MENLO PARK